Full-Time
Operations and Planning Manager
agilon health
501-1,000 employees
Value-based primary care platform for seniors
No salary listed
No H1B Sponsorship
Jackson, TN, USA
In Person
Only candidates in Jackson, Tennessee will be considered.
Bachelor's, Master's
 Business & Strategy (1) |
|---|
Get referred to agilon health
See people who can refer or advise you
- Candidates must be legally authorized to work in the United States without employer sponsorship, now or in the future.
- At least 4 years of experience leading projects or driving initiatives.
- A demonstrated track record of innovative thinking across the continuum of patient care.
- The ability to manage ambiguity, devise solutions when a clear path does not exist, and function effectively in team-based environments.
- Proven skills in developing, implementing, and executing project plans and integrating complex operations.
- Advanced Microsoft Excel skills to manipulate data and analyze large data sets.
- The ability to create clear, board-ready, and convincing presentations and communications.
- The ability to cultivate an active network of internal and external relationships and relate well to colleagues at all levels.
- The ability to handle confidential and sensitive information and situations.
- The ability to drive change while maintaining operating effectiveness and align efforts across physician practices, corporate functions, and business units.
- A Bachelor's degree.
- Strong written and verbal communication skills.
- The ability to apply probability, statistical inference, fractions, percentages, ratios, and proportions to practical situations.
- The ability to apply logical or scientific thinking to a wide range of intellectual and practical problems.
- The ability to create and maintain documents using Microsoft Office, including Word, Excel, Outlook, and PowerPoint.
- Oversee strategic planning and execution of key activities within the RBE and between agilon health.
- Provide leadership and participate in implementing business strategies and initiatives that align priorities with company and business goals and objectives.
- Support the RBE infrastructure with an ongoing focus on organizational effectiveness and continued integration between agilon health and physician partners.
- Develop processes and lead initiatives to improve quality of care, efficiency, and growth in the market.
- Function as part of the market leadership team to drive initiatives with provider partners, payers, and the enterprise that support the RBE partnership.
- Support the development of innovative care models with agilon health and provider-group clinical leadership teams to improve patient experience and quality of care.
- Support prioritization, metric development and tracking, and return-on-investment analysis for new and ongoing projects.
- Drive high-quality results by supporting organizational needs.
- Leverage technology to drive process improvement, operational efficiency, and improved clinical results.
- Establish performance objectives, track performance, and evaluate progress toward unit and organizational goals.
- Understand, adhere to, and implement company policies and procedures.
- Provide customer service to internal and external clients by identifying and addressing their needs.
- Take responsibility for personal growth by acquiring new skills, knowledge, and information.
- Set and complete challenging goals.
- Demonstrate attention to detail and accuracy in work products.
- A Master's degree.
agilon health builds a Medicare-focused value-based primary care network. It partners with independent primary care physicians to deliver senior care through a unified operating platform that connects payors, physicians, and patients. The platform combines people, processes, and technology to help physician partners close gaps in care, integrate with payors, and grow their practices, while enabling predictable margins and improved patient experience. Unlike models that push physicians to join large owned practices, agilon health keeps clinicians independent and supports them with coordinated care delivery and financial certainty. The company’s goal is to improve health outcomes for seniors by expanding access to quality primary care, aligning incentives across physicians, payors, and patients, and driving value-based care at scale.
Company Size
501-1,000
Company Stage
IPO
Headquarters
Long Beach, California
Founded
2016
Get referred to agilon health
See people who can refer or advise you
Simplify's Take
What believers are saying
- August 5, 2026 revenue hit $1.49 billion, with adjusted EBITDA of $70 million.
- Management raised 2026 revenue guidance to $5.82 billion and EBITDA to $85 million.
- Tim O'Rourke said on August 27, 2026, Jefferies access supports investor visibility.
What critics are saying
- Kaskela Law launched an August 2026 investigation over prior guidance and medical-cost disclosures.
- The Schall Law Firm's February 2026 class action targets 2025 disclosures.
- Member counts fell from 511,000 to 426,000 in Q1 2026, exposing contracting dependence.
What makes agilon health unique
- agilon's Total Care Model links 2,300 PCPs across 30 communities, preserving physician independence.
- On August 5, 2026, Tim O'Rourke credited payer data pipelines covering 85% of members.
- agilon combines technology, capital, and care management, unlike referral-based physician groups.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↓ -1%2 year growth
↑ 0%agilon health announces revised presentation time at the 2026 Jefferies Healthcare Services and Technology Conference. Key Takeaway: Agilon Health has announced a change in the timing of its presentation at the 2026 Jefferies Healthcare Services and Technology Conference. The management team will now participate in a fireside chat scheduled for 4:00 PM ET on September 14, 2026. Investors can access the presentation through a webcast. Market sentiment analysis. Positive factors. * Agilon Health is actively engaging with investors. * The company is participating in a significant healthcare conference. * The revised presentation time allows for broader audience access. WESTERVILLE, Ohio-(BUSINESS WIRE)-agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in its communities, today announced that its management team will now participate in a fireside chat at the 2026 Jefferies Healthcare Services and Technology Conference at 4:00pm ET on Monday, September 14, 2026. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the "Events & Presentations" section o Frequently asked questions. What is the new presentation time for Agilon Health? The new presentation time is 4:00 PM ET on September 14, 2026. Where can I listen to the Agilon Health presentation? The presentation can be accessed via a webcast in the 'Events & Presentations' section. What type of event is Agilon Health participating in? Agilon Health is participating in the 2026 Jefferies Healthcare Services and Technology Conference.
Agilon Health reported second-quarter results that significantly beat revenue and profitability expectations, though shares fell following the announcement. Revenue reached $1.49 billion, beating analyst estimates of $1.45 billion, whilst adjusted earnings per share hit $2.15 versus the $0.27 forecast. CEO Tim O'Rourke attributed the strong performance to operational improvements, including earlier identification of high-risk conditions and expanded clinical pathways, particularly in chronic heart failure management. The company's enhanced data pipeline and AI investments also contributed to better outcomes and reduced medical costs. The company raised its full-year revenue guidance to $5.82 billion at the midpoint, up from $5.74 billion. Customer numbers grew to 549,000 from 426,000 in the previous quarter. During the earnings call, analysts questioned the sustainability of improved margins and cost moderation trends, with management highlighting that over 80% of payers are now integrated into the enhanced data pipeline.
Agilon Health reported second-quarter revenue of approximately $1.5 billion, medical margin of $197 million, and adjusted EBITDA of $70 million, exceeding guidance and reversing prior-year losses of $53 million and $83 million respectively. The company raised its 2026 outlook to roughly $5.8 billion in revenue, $485 million in medical margin, and $85 million in adjusted EBITDA. The improvements were driven by stronger risk-adjustment revenue and favorable medical-cost trends, despite lower Medicare Advantage membership. Medicare Advantage membership stood at 437,000 at quarter-end, down from 498,000 a year earlier but up from 426,000 in the first quarter. CEO Tim O'Rourke emphasised operational consistency and clinical programmes for conditions including heart failure, COPD, and dementia, whilst prioritising growth in existing markets.
Healthcare services company Agilon Health reported second-quarter 2026 revenue of $1.49 billion, beating analyst estimates of $1.45 billion and representing 7.2% year-on-year growth. The company also exceeded expectations for GAAP profit, reporting $1.04 per share against analyst estimates of $0.01. Agilon raised its full-year revenue guidance to $5.82 billion at the midpoint, up from $5.74 billion previously. The company's adjusted EBITDA of $70 million significantly beat analyst estimates of $19.95 million. The platform provider for value-based care models reported 549,000 customers in the quarter, up from 426,000 in the previous quarter. Operating margin improved to 0.8%, compared with negative 8.3% in the same quarter last year.
Agilon Health (NYSE:AGL) releases earnings results, beats estimates by $0.92 EPS. August 5, 2026 Key points. * Agilon Health beat quarterly earnings expectations: The company reported $1.04 in EPS, exceeding the $0.12 consensus estimate by $0.92, while revenue reached $1.49 billion versus expectations of $1.45 billion. * Shares surged 12.4% to $106.55 following the earnings release, although the stock remains highly volatile, with a beta of 3.01 and a 52-week range of $7.48 to $133.04. * Analyst sentiment remains mixed despite several upgrades: Agilon has five Buy, six Hold, and three Sell ratings, producing a consensus rating of Hold and an average price target of $66.50. * MarketBeat previews the top five stocks to own by September 1st. Agilon Health (NYSE:AGL - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $1.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.12 by $0.92, FiscalAI reports. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The business had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.45 billion. Agilon Health stock up 12.4%. AGL stock traded up $11.77 during mid-day trading on Wednesday, reaching $106.55. The company had a trading volume of 1,112,918 shares, compared to its average volume of 354,822. The company has a market capitalization of $1.78 billion, a price-to-earnings ratio of -4.94 and a beta of 3.01. Agilon Health has a 52 week low of $7.48 and a 52 week high of $133.04. The stock has a 50 day simple moving average of $106.46 and a two-hundred day simple moving average of $54.68. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04. Analyst ratings changes. A number of research firms have weighed in on AGL. Jefferies Financial Group raised Agilon Health from a "hold" rating to a "buy" rating and upped their price target for the stock from $27.50 to $48.00 in a research report on Thursday, May 7th. Deutsche Bank Aktiengesellschaft raised shares of Agilon Health from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $33.00 to $49.00 in a research report on Thursday, May 7th. Wells Fargo & Company restated an "overweight" rating and set a $141.00 target price (up from $72.00) on shares of Agilon Health in a report on Monday, July 13th. JPMorgan Chase & Co. downgraded shares of Agilon Health from a "neutral" rating to an "underweight" rating and set a $21.00 target price for the company. in a research report on Monday, May 4th. Finally, Benchmark reissued a "buy" rating and set a $95.00 price target (up from $13.00) on shares of Agilon Health in a research report on Thursday, May 21st. Five research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $66.50. Discover more Financial News Subscription Stock Profit Calculator Dividend Screener Tool Hedge funds weigh in on Agilon Health. Several hedge funds and other institutional investors have recently made changes to their positions in the company. CIBC Bancorp USA Inc. bought a new stake in Agilon Health during the third quarter worth $34,000. Tower Research Capital LLC TRC grew its position in shares of Agilon Health by 214.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 37,079 shares of the company's stock valued at $85,000 after acquiring an additional 25,270 shares during the period. Prudential Financial Inc. increased its stake in shares of Agilon Health by 70.7% during the 2nd quarter. Prudential Financial Inc. now owns 40,880 shares of the company's stock worth $94,000 after purchasing an additional 16,928 shares during the last quarter. LPL Financial LLC increased its stake in shares of Agilon Health by 213.4% during the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company's stock worth $30,000 after purchasing an additional 30,000 shares during the last quarter. Finally, WINTON GROUP Ltd bought a new stake in shares of Agilon Health in the 2nd quarter valued at about $106,000. Agilon Health company profile. Agilon Health NYSE: AGL is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery. Agilon's platform encompasses data analytics, care management, patient engagement tools and population health programs. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Continue following MarketBeat Before you consider Agilon Health, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list. While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you'll find 7 stocks that could play a major role in the next tech-driven market boom.